Haikou Mingheng Biotechnology
Ordered peptides from Haikou Mingheng Biotechnology? Mail in a sample (US only) and let us test it.
Test my supplyHaikou Mingheng Biotechnology's Purity focus record is strongest in Tirzepatide, with recent high-purity results after earlier purity and overfill misses. Retatrutide and Cagrilintide are more dispersed, with notable purity/fill failures before a later rebound; evidence is current and moderate in volume, but batch IDs remain absent/thin.
Storefront records point to a Haikou trader network rather than a verified synthesis lab, with name drift across Biotechnology, Technology, and Pharmaceutical channels. The report follows the xtmingheng.com email trail, COA discrepancy, and forum clustering lead.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Haikou Mingheng Biotechnology rows.
Cancel anytime
Ordered peptides from Haikou Mingheng Biotechnology? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
21 Sep 2026 | Pass | Tirzepatide Haikou Mingheng Biotechnology | lab name | View COA | |||
16 Sep 2026 | Fail | Retatrutide Haikou Mingheng Biotechnology | lab name | View COA | |||
16 Sep 2026 | Fail | Retatrutide Haikou Mingheng Biotechnology | lab name | View COA | |||
15 Sep 2026 | Pass | GHK-Cu Haikou Mingheng Biotechnology | lab name | View COA | |||
9 Aug 2026 | Pass | Tirzepatide Haikou Mingheng Biotechnology | lab name | View COA | |||
16 Jun 2026 | Pass | Tirzepatide Haikou Mingheng Biotechnology | lab name | View COA | |||
20 May 2026 | Pass | Retatrutide Haikou Mingheng Biotechnology | lab name | View COA | |||
28 Apr 2026 | Pass | Retatrutide Haikou Mingheng Biotechnology | lab name | View COA | |||
28 Apr 2026 | Pass | Cagrilintide Haikou Mingheng Biotechnology | lab name | View COA | |||
28 Apr 2026 | Pass | Retatrutide Haikou Mingheng Biotechnology | lab name | View COA | |||
About Haikou Mingheng Biotechnology test results from Finnrick
Haikou Mingheng Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 33 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Haikou Mingheng Biotechnology peptides in this dataset are Cagrilintide (7 tests), GHK-Cu (3 tests) and Retatrutide (11 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 33 recent tests.
Ordered peptides from Haikou Mingheng Biotechnology? Mail in a sample (US only) and let us test it.
Test my supply